• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSB2400169 阿替利珠单抗注射液(皮下注射) atezolizumab Injection Biological Products(2.2) Supplementary Application 2024-12-14 Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG view
JXSS2400063 阿替利珠单抗注射液(皮下注射) atezolizumab Injection Biological Products(3.1) Import Drug Application 2024-07-27 Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH view
JXSB2400168 阿替利珠单抗注射液(皮下注射) atezolizumab Injection Biological Products(3.1) Supplementary Application 2024-12-14 Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG view
JXSS2400064 阿替利珠单抗注射液(皮下注射) atezolizumab Injection Biological Products(2.2) Import Drug Application 2024-07-27 Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH view
JXSS2101014 阿替利珠单抗注射液 atezolizumab Injection Biological Products(2.2) Import Drug Application 2021-06-30 Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH view
JXSL2000088 阿替利珠单抗注射液 atezolizumab Injection Biological Products Import Drug Application 2020-07-03 F.Hoffmann-La Roche Ltd F Hoffmann-La Roche Ltd(Switzerland) In Review 2020-07-02 view
JYSB2400218 阿替利珠单抗注射液 atezolizumab Injection Biological Products Supplementary Application 2024-09-28 Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland);Roche Registration GmbH view
JXSL2000160 阿替利珠单抗注射液 atezolizumab Injection Biological Products(3.1) Import Drug Application 2020-09-24 F Hoffmann-La Roche Ltd(Switzerland) In Review 2020-09-23 view
JXSL1900106 阿替利珠单抗注射液 atezolizumab Injection Biological Products Import Drug Application 2019-10-23 罗氏(中国)投资有限公司 Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) In Review 2019-10-22 view
JXSL2101067 阿替利珠单抗注射液 atezolizumab Injection Biological Products(2.2) Import Drug Application 2021-07-20 F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd view
JXSL2100001 阿替利珠单抗注射液 atezolizumab Injection Biological Products(2.2) Import Drug Application 2021-01-06 罗氏(中国)投资有限公司 Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) In Review 2021-01-05 view
JXSL2000043 阿替利珠单抗注射液 atezolizumab Injection Biological Products Import Drug Application 2020-05-11 F.Hoffmann-La Roche Ltd F Hoffmann-La Roche Ltd(Switzerland) In Review 2020-05-10 view
JXSB2400102 阿替利珠单抗注射液 atezolizumab Injection Biological Products(2.2) Supplementary Application 2024-07-25 Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) view
JXSS1900004 阿替利珠单抗注射液 atezolizumab Injection Biological Products Import Drug Application 2019-02-25 Roche Diagnostics GmbH;Roche Registration GmbH Certificate Issued 2020-02-13 view
JXSB2101001 阿替利珠单抗注射液 atezolizumab Injection Biological Products(2.1) Supplementary Application 2021-04-01 Genentech Inc;F Hoffmann-La Roche Ltd(Switzerland) view
JYSB2000352 阿替利珠单抗注射液 atezolizumab Injection Biological Products Supplementary Application 2020-07-30 Roche Diagnostics GmbH;Roche Registration GmbH Filed 2020-08-17 view
JYSB2500118 阿替利珠单抗注射液 atezolizumab Injection Biological Products Supplementary Application 2025-05-21 Roche Registration GmbH view
JXSL1900100 阿替利珠单抗注射液 atezolizumab Injection Biological Products Import Drug Application 2019-09-28 罗氏(中国)投资有限公司 Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) In Review 2019-09-27 view
JXSL2000205 阿替利珠单抗注射液 atezolizumab Injection Biological Products(2.2) Import Drug Application 2020-11-28 罗氏(中国)投资有限公司 Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) In Review 2020-11-27 view
JXSS2000002 阿替利珠单抗注射液 atezolizumab Injection Biological Products Import Drug Application 2020-02-15 罗氏(中国)投资有限公司 Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Registration GmbH Certificate Issued 2020-10-29 view